Routine esophageal screening critical for HNSCC patients
May 24, 2013 -- Routine esophageal screening can increase the early detection of second primary esophageal squamous cell carcinoma in patients with head and neck squamous cell carcinoma (HNSCC), according to a study in JAMA Otolaryngology -- Head and Neck Surgery.
Heartburn increases risk for throat cancer
May 24, 2013 -- Gastric reflux increases the risk for laryngopharyngeal squamous cell carcinoma, but antacids may provide protection, according to a new study in Cancer Epidemiology, Biomarkers & Prevention.
Leaders in Dentistry: Dr. Ezra Cohen
May 21, 2013 -- Ezra Cohen, MD, an associate professor of medicine and the co-director of the head and neck cancer program at the University of Chicago, has spent much of his career studying head and neck, thyroid, and salivary gland cancers and therapies. What does he see as the next big advance in oral cancer diagnosis and treatment?
Genetic diversity predicts head/neck cancer
May 20, 2013 -- A new measure of the heterogeneity of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer, according to a new study in Cancer.
Wide-area biopsy can detect esophageal dysplasia
May 20, 2013 -- CDx Diagnostics has released data that support the company's WATS3D (wide-area transepithelial sample biopsy with 3D analysis) as an additional surveillance tool to increase detection of dysplasia and Barrett's esophagus.
U.S. teens' smokeless tobacco usage not declining
May 14, 2013 -- Declines in smoking among U.S. youths have been observed since the late 1990s. However, limited information exists on trends in smokeless tobacco use among U.S. youths, according to a research letter in the Journal of the American Medical Association.
Study examines role of DNA, HPV in oral cancer survival
May 13, 2013 -- To better understand the molecular mechanisms underlying the differences in survival for oropharyngeal squamous cell carcinoma (OPSCC) patients with and without human papillomavirus (HPV), researchers from Germany monitored changes in DNA modifications in HPV-positive and HPV-negative OPSCCs.